Sales rise 21.60% to Rs 4.11 crore
Net loss of Parmax Pharma reported to Rs 0.29 crore in the quarter ended June 2019 as against net profit of Rs 0.06 crore during the previous quarter ended June 2018. Sales rose 21.60% to Rs 4.11 crore in the quarter ended June 2019 as against Rs 3.38 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales4.113.38 22 OPM %-1.959.76 -PBDT-0.070.32 PL PBT-0.290.06 PL NP-0.290.06 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
